Vitamin B12 drops are liquid nutritional supplements delivering cyanocobalamin or methylcobalamin via oral administration, primarily targeting infants, adults, and seniors who seek convenient, high‑bioavailability intake. The Vitamin B12 Drops market size is projected to reach approximately $260 million in 2025, with a growth outlook indicating a CAGR of 7.2% through the market forecast period 2026‑2033, driven by rising age‑related deficiency awareness, expanding pediatric nutrition programs, and increasing preference for non‑tablet delivery formats. Key forces shaping the industry include evolving consumer health consciousness, stricter fortification regulations in major economies, and intensified competition among specialty nutraceutical manufacturers leveraging advanced liquid‑encapsulation technologies. North America remains the largest region, while the Asia‑Pacific is emerging as the fastest‑growing market due to demographic shifts and rising disposable incomes.